Showing 1 - 3 results of 3 for search 'Peter Ejou', query time: 0.02s
Refine Results
-
1
The single-dose Janssen Ad26.COV2.S COVID-19 vaccine elicited robust and persistent anti-spike IgG antibody responses in a 12-month Ugandan cohort by Jennifer Serwanga, Jennifer Serwanga, Laban Kato, Gerald Kevin Oluka, Gerald Kevin Oluka, Violet Ankunda, Jackson Sembera, Claire Baine, Isaac Kitabye, Angela Namuyanja, Solomon Opio, Joseph Ssebwana Katende, Joseph Ssebwana Katende, Peter Ejou, The COVID-19 Immunoprofiling Team, The COVID-19 Immunoprofiling Team, Pontiano Kaleebu, Pontiano Kaleebu
Published 2024-05-01
Article -
2
Sustained S-IgG and S-IgA antibodies to Moderna’s mRNA-1273 vaccine in a Sub-Saharan African cohort suggests need for booster timing reconsiderations by Jennifer Serwanga, Jennifer Serwanga, Violet Ankunda, Joseph Ssebwana Katende, Joseph Ssebwana Katende, Claire Baine, Gerald Kevin Oluka, Gerald Kevin Oluka, Geoffrey Odoch, Hellen Nantambi, Susan Mugaba, Angella Namuyanja, Ivan Ssali, Peter Ejou, Laban Kato, The COVID-19 Immunoprofiling Team, The COVID-19 Immunoprofiling Team, Monica Musenero, Pontiano Kaleebu, Pontiano Kaleebu, Jackson Sembera, Betty Oliver Auma, Solomon Opio, Ben Gombe
Published 2024-01-01
Article -
3
The subdued post-boost spike-directed secondary IgG antibody response in Ugandan recipients of the Pfizer-BioNTech BNT162b2 vaccine has implications for local vaccination policies by Violet Ankunda, Joseph Ssebwana Katende, Joseph Ssebwana Katende, Gerald Kevin Oluka, Gerald Kevin Oluka, Jackson Sembera, Claire Baine, Geoffrey Odoch, Peter Ejou, Laban Kato, The COVID-19 Immunoprofiling Team, The COVID-19 Immunoprofiling Team, Pontiano Kaleebu, Pontiano Kaleebu, Jennifer Serwanga, Jennifer Serwanga, Christine Hermilia Akoli, Angela Namuyanja, Solomon Opio, Arthur Watelo Kalyebi, Ivan Ssali, Ben Gombe, Susan Mugaba, Hellen Nantambi
Published 2024-02-01
Article